Overall survival (OS) analysis from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) Meeting Abstract
| Authors: | Hogg, D.; Chapman, P. B.; Sznol, M.; Lao, C. D.; Gonzalez, R.; Daniels, G. A.; Smylie, M.; Kudchadkar, R. R.; Thompson, J. A.; Sharfman, W. H.; Atkins, M. B.; Pavlick, A. C.; Jiang, J.; Avila, A.; Demelo, S.; Hodi, F. S. |
| Abstract Title: | Overall survival (OS) analysis from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 481s |
| Language: | English |
| ACCESSION: | WOS:000411932203165 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.9522 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9522 -- Source: Wos |
